Search

Search Constraints

You searched for: Author/Creator Kopetz, S

Search Results

2. 487PPatient selection for targeting integrin with abituzumab in patients with metastatic colorectal cancer (mCRC): A retrospective analysis of the randomized phase I/II Poseidon study. (23rd October 2018)

3. Anti-EGFR-resistant clones decay exponentially after progression: implications for anti-EGFR re-challenge. (21st November 2018)

4. Cell membrane-anchored and tumor-targeted IL-12 (attIL12)-T cell therapy for eliminating large and heterogeneous solid tumors. Issue 1 (13th January 2022)

6. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. (23rd August 2018)

7. Contour prognostic model for predicting survival after resection of colorectal liver metastases: development and multicentre validation study using largest diameter and number of metastases with RAS mutation status. Issue 8 (7th April 2021)

8. LBA-006BEACON CRC: a randomized, 3-Arm, phase 3 study of encorafenib and cetuximab with or without binimetinib vs. choice of either irinotecan or FOLFIRI plus cetuximab in BRAF V600E–mutant metastatic colorectal cancer. (2nd July 2019)

9. O-027BEACON CRC study safety lead-in: Assessment of the BRAF inhibitor encorafenib + MEK inhibitor binimetinib + anti–epidermal growth factor receptor antibody cetuximab for BRAFV600E metastatic colorectal cancer. (20th June 2018)

10. P-002A novel patient derived orthotopic xenograft model of gastro-esophageal junction cancer: Key platform for translational discoveries. (20th June 2018)